Search

Guava (Psidium guajava L.) is a widely cultivated tropical fruit crop consumed raw and also in the form of processed products. Winters in Punjab show a drop in temperature, which hardens the fruit. Therefore, manipulation of the flowering season is desirable. Hence, the present study aimed to select an adequate combination of plant hormones and branch bending to amplify the quantitative traits in Guava cv. Allahabad Safeda. For combinations, three months for branch bending viz., August, September and October and three plant hormones: Naphthaleneacetic acid, Ethrel, and Gibberellins, with two different concentrations each (NAA@100ppm, NAA@200ppm, Ethrel@200ppm, Ethrel@400ppm, GA3@100ppm, GA3@150ppm were selected. The experimental layout was planned in two two-factor randomized block design (RBD) with twenty-one treatments. In the case of branch bending months, (M1) August branch bending gained ideal values in comparison with (M2) September and (M3) October. Combination of NAA at the rate of 200ppm with August branch bending (T2) gave more pronounced results for almost all vegetative parameters, while amongst plant hormones NAA at 200 ppm (C2) enhanced results for Canopy spread (N-S), canopy spread (E -W), length of internode and days for the emergence of new leaf 0.837m and 0.803m, 14.1cm and 27.33 respectively. Results vividly provide a strong base for selecting a combination of NAA spray at 200ppm concentration and August month for branch bending to uplift morphological traits in guava. Thus, these findings will favour horticulture breeders and farmers in harvesting profitable gains for field parameters by selecting a better combination of PGR and crop regulation measures from the offseason. [ABSTRACT FROM AUTHOR]

Urinary tract infections (UTI) is a broad term encompassing the urothelium's inflammatory reaction to bacterial invasion, characterized by the presence of bacteria and pus cells. It can manifest anywhere along the urinary tract and can have insidious onset which can be asymptomatic bacteriuria or may present with acute onset of symptoms like in case of cystitis or pyelonephritis. This review aims to determine the causation of UTI during pregnancy and elucidates the methods for diagnosing UTI in pregnant women. We concisely outline the array of treatment alternatives accessible to pregnant patients with UTI aiming to enhance care and outcomes for expectant mothers afflicted with UTI. [ABSTRACT FROM AUTHOR]

Background: Perinatal deaths due to hypoxia are preventable with continuous monitoring. Cardiotocography (CTG) is standard for intrapartum foetal assessment, aiming to detect signs of distress and intervene promptly to mitigate risk. Objective: To determine the accuracy of advanced intrapartum monitoring system in comparison with electronic CTG in tracking of non-reassuring foetal symptoms by pattern analysis of the FHR. Materials and methods: A single-centre, observation study was conducted at a tertiary care hospital from January 2020 to December 2021. CTG and an advanced portable intrapartum monitoring system (KEYAR) were applied simultaneously to all participants. Twenty-minute-long recording traces were obtained from both devices. Mode of delivery was noted for all patients along with Apgar score at 1 minute and 5 minutes. Results: The final study cohort was constituted by 94 participants. Most participants (57.4%) were primigravida. The mean (95% CI) sensitivity, specificity, positive predictive value and negative predictive value of KEYAR tracing were 33% (9.6, 70), 97.7% (92.09, 99.37), 50% (15, 85) and 95.5% (89.12, 98.26), respectively. The overall, diagnostic accuracy of KEYAR was 93.6% (86.77, 97.04). Conclusions: Advanced portable intrapartum monitoring device (KEYAR) is a new application with the benefits of easy user operability and portability. [ABSTRACT FROM AUTHOR]

The Indian Obstetrics & Gynaecology journal presents its most recent issue, featuring a range of research articles and case reports in the field. The articles cover topics such as gestational weight gain and birth weight correlation, the relationship between vitamin D3 levels and foetal distress, the use of portable intrapartum monitoring devices, hypertensive intracranial haemorrhage in advanced pregnancy, urinary tract infections in pregnancy, and the use of telemedicine services in Obstetrics and Gynecology. The journal also includes case reports on retroperitoneal endocrine neoplasms and ovarian ligament adenomyoma, as well as a case series on hysteroscopic cervical shaving. The editorial team expresses gratitude to the authors, reviewers, and staff for their contributions, and encourages further submissions to advance clinical medicine. [Extracted from the article]

Objective: We conducted a meta-analysis of randomized clinical trials evaluating the clinical effects of ferric carboxymaltose therapy compared to other intravenous iron in improving hemoglobin and serum ferritin in pregnant women. We also assessed the safety of ferric carboxymaltose vs. other intravenous iron., Data Source: EMBASE, PubMed, and Web of Science were searched for trials related to ferric carboxymaltose in pregnant women, published between 2005 and 2021. We also reviewed articles from google scholar. The keywords "ferric carboxymaltose," "FCM," "intravenous," "randomized," "pregnancy," "quality of life," and "neonatal outcomes" were used to search the literature. The search was limited to pregnant women., Selection of Studies: Studies related to ferric carboxymaltose in pregnancy were scanned. Observational studies, review articles, and case reports were excluded. Randomized studies in pregnant women involving ferric carboxymaltose and other intravenous iron formulations were shortlisted. Of 256 studies, nine randomized control trials were selected., Data Collection: Two reviewers independently extracted data from nine selected trials., Data Synthesis: The final effect size for increase in hemoglobin after treatment was significant for ferric carboxymaltose vs. iron sucrose/iron polymaltose (standard mean difference 0.89g/dl [95% confidence interval 0.27,1.51]). The final effect size for the increase in ferritin after treatment was more for ferric carboxymaltose vs. iron sucrose/iron polymaltose (standard mean difference 22.53µg/L [-7.26, 52.33]). No serious adverse events were reported with ferric carboxymaltose or other intravenous iron., Conclusion: Ferric carboxymaltose demonstrated better efficacy than other intravenous iron in increasing hemoglobin and ferritin levels in treating iron deficiency anemia in pregnant women., Competing Interests: Conflicts to interest: none to declare., (© 2024. Federação Brasileira de Ginecologia e Obstetrícia. All rights reserved.)